Study identifies C1orf122 as prognostic marker in liver cancer
Primary liver cancer is the third leading cause of cancer-related deaths, of which hepatocellular carcinoma (HCC) accounts for…
Mapping the evolutionary trajectory of meningiomas at single-cell resolution
Meningiomas are the most common primary brain tumors, accounting for nearly one-third of all central nervous system (CNS)…
Targeting telomere damage offers new path to boost cancer immunotherapy
Tumors are stressful places for cancer-fighting immune cells. Low oxygen, high acid levels, and other stressors put strain…
‘Rogue’ DNA rings identified as drivers of aggressive brain cancer
An international team of scientists has revealed how rogue rings of DNA that float outside of our chromosomes…
Targeting metabolic reprogramming to overcome immune suppression in head and neck cancer
Head and neck cancer remains a major global health challenge, ranking among the six most common cancers worldwide…
NYU Langone strengthens world-leading GI cancer program with renowned leaders
NYU Langone Health’s Perlmutter Cancer Center announces the arrival of acclaimed cancer leaders Anirban Maitra, MD, and Manuel…